CONSIDER PHARMACOKINETICS
OF TYSABRI1

  • Half-life (mean ± SD): 11 ± 4 days
  • Volume of distribution (mean ± SD): 5.7 ± 1.9 L
  • Clearance (mean ± SD): 16 ± 5 mL/hour
  • Time to steady-state: ~24 weeks after every 4 weeks of dosing